Clinical Trial Update: Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

This notice reports the termination of a Phase 1 clinical trial studying monoclonal antibody 216 in combination with chemotherapy for children with relapsed or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• mAb 216

Snippet

Sponsor: Clare Twist | Conditions: Leukemia, Lymphocytic, Acute, Leukemia | Phase 1 | Status: TERMINATED